Raymond C. Bergan

Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion.

Some aspects of analysis of gene array data.

An analysis of gene array data related to cell adhesion and prostate cancer.

p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion.

Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.

Safety and efficacy of weekly oral oltipraz in chronic smokers.

Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells.

Renal medullary carcinoma and ABL gene amplification.

Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer.

Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway.

Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells.

Associations of serum carotenoid levels with serum insulin-like growth factor-i and insulin-like growth factor binding protein-3 levels in black men and white men.

The methodology used to measure differential gene expression affects the outcome.

Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.

Dietary genistein inhibits metastasis of human prostate cancer in mice.

Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images.

MEK4 function, genistein treatment, and invasion of human prostate cancer cells.

Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration.

Inhibition of cancer cell invasion and metastasis by genistein.

Endoglin suppresses human prostate cancer metastasis.

Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression.

Endoglin regulates cancer-stromal cell interactions in prostate tumors.

The Ninth Annual American Association of cancer research international conference on frontiers in cancer prevention research.

Soy Isoflavone Supplementation for Breast Cancer Risk Reduction: A Randomized Phase II Trial.

Crystal structure of a type II dehydroquinate dehydratase-like protein from Bifidobacterium longum.

Androgen receptor-independent function of FoxA1 in prostate cancer metastasis.

A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia.

Endoglin-Mediated Suppression of Prostate Cancer Invasion Is Regulated by Activin and Bone Morphogenetic Protein Type II Receptors.